Rockwell Medical Announces Date Change for Third Quarter 2024 Earnings Conference Call and Webcast

Rhea-AI Summary

Rockwell Medical (Nasdaq: RMTI) has rescheduled its third quarter 2024 earnings release and conference call to Tuesday, November 12, 2024, due to SEC EDGAR system closure on November 11 for Veterans Day. The company will issue its financial and operational results press release at 6:00am ET, followed by a live conference call and webcast at 8:00am ET. The call will discuss Q3 2024 results and include a Q&A session.

Due to the U.S. Securities and Exchange Commission (SEC) and its Electronic Data Gathering, Analysis, and Retrieval (EDGAR) system being closed on Monday, November 11, 2024 in observance of Veteran's Day, the Company will release its financial and operational results for the Third Quarter 2024 on Tuesday, November 12, 2024

Press release will be issued at 6:00am ET followed by a live conference call and webcast at 8:00am ET

WIXOM, Mich.--(BUSINESS WIRE)-- Rockwell Medical, Inc. (the "Company") (Nasdaq: RMTI), a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products to dialysis providers worldwide, today announced that it has updated the date for its third quarter 2024 earnings conference call and webcast and will now release its financial and operational results for the third quarter ended September 30, 2024 on Tuesday, November 12, 2024. The Company will issue a press release at 6:00am ET followed by a live conference call and webcast at 8:00am ET.

CONFERENCE CALL AND WEBCAST DETAILS

Date: Tuesday, November 12, 2024

Time: 8:00am ET

Live Number: (888) 660-6347 // (International) 1 (929) 201-6594

Conference Call ID: 4944610

Webcast and Replay: www.RockwellMed.com/Results

Format: Discussion of third quarter 2024 financial and operational results followed by Q&A.

ABOUT ROCKWELL MEDICAL

Rockwell Medical, Inc. (Nasdaq: RMTI) is a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products for dialysis providers worldwide. Rockwell Medical's mission is to provide dialysis clinics and the patients they serve with the highest quality products supported by the best customer service in the industry. Rockwell is focused on innovative, long-term growth strategies that enhance its products, its processes, and its people, enabling the Company to deliver exceptional value to the healthcare system and provide a positive impact on the lives of hemodialysis patients. Hemodialysis is the most common form of end-stage kidney disease treatment and is usually performed at freestanding outpatient dialysis centers, at hospital-based outpatient centers, at skilled nursing facilities, or in a patient’s home. Rockwell Medical's products are vital to vulnerable patients with end-stage kidney disease, and the Company is relentless in providing unmatched reliability and customer service. Certified as a Great Place to Work^® in 2023 and 2024 and named Fortune Best Workplaces in Manufacturing & Production^TM in 2024, Rockwell Medical is Driven to Deliver Life-Sustaining Dialysis Solutions^TM. For more information, visit www.RockwellMed.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20241108539368/en/

Heather R. Hunter

SVP, Chief Corporate Affairs Officer

(248) 432-1362

IR@RockwellMed.com

Source: Rockwell Medical

FAQ

When will Rockwell Medical (RMTI) release Q3 2024 earnings?

Rockwell Medical will release Q3 2024 earnings on Tuesday, November 12, 2024, with a press release at 6:00am ET and conference call at 8:00am ET.

Why did RMTI change its Q3 2024 earnings release date?

RMTI changed the date due to SEC EDGAR system closure on Monday, November 11, 2024, in observance of Veterans Day.

How can investors access RMTI's Q3 2024 earnings call?

Investors can access the call at 8:00am ET on November 12, 2024, via phone (888) 660-6347 (US) or 1 (929) 201-6594 (International) with ID 4944610, or through webcast at www.RockwellMed.com/Results.